tiprankstipranks
Advertisement
Advertisement

Agronomics portfolio firm All G wins FDA green light for precision fermented lactoferrin

Story Highlights
  • All G secures FDA GRAS clearance for its precision fermented lactoferrin, enabling U.S. commercialisation.
  • Agronomics expects the milestone to de-risk All G’s path to revenues and strengthen its precision fermentation strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Agronomics portfolio firm All G wins FDA green light for precision fermented lactoferrin

Meet Samuel – Your Personal Investing Prophet

Agronomics ( (GB:ANIC) ) has shared an announcement.

Agronomics said its portfolio company All G Co Holdings has received a U.S. FDA “no questions” letter for its precision fermented bovine lactoferrin, completing the GRAS notification process and clearing the way for commercialisation in the U.S. functional ingredients and dietary supplements market. The Australian biotech’s recombinant lactoferrin, branded LFX™, is aimed at functional foods, beverages, dietary supplements and early life nutrition, with purity levels above 99.5% and a controlled fermentation process.

Agronomics views this regulatory milestone as reducing commercial uncertainty for All G and the wider precision fermentation sector, supporting a shift from technical development to revenue generation. With lactoferrin demand outstripping traditional supply and attractive pricing dynamics, the clearance is expected to underpin All G’s growth in global nutrition markets and feed into its broader regulatory and geographic expansion plans, while Agronomics’ £8.9 million investment, including a recent AU$3 million convertible loan, gains a clearer commercial pathway.

The most recent analyst rating on (GB:ANIC) stock is a Sell with a £6.50 price target. To see the full list of analyst forecasts on Agronomics stock, see the GB:ANIC Stock Forecast page.

Spark’s Take on ANIC Stock

According to Spark, TipRanks’ AI Analyst, ANIC is a Neutral.

The score is weighed down primarily by weak financial performance (recent losses and persistently negative cash flow), with technicals also bearish (price below key moving averages and negative MACD). Valuation is additionally constrained by a negative P/E driven by losses and no dividend data to offset risk; the main positive is the debt-free balance sheet, though equity has been eroding.

To see Spark’s full report on ANIC stock, click here.

More about Agronomics

Agronomics Limited is a London-listed investment company focused on the clean food sector, with a diversified portfolio spanning cellular agriculture, precision fermentation and enabling biomanufacturing technologies. The firm targets scalable, high-value food and nutrition ingredients and related platforms, aiming to capture growth in alternative proteins and sustainable food production markets.

Average Trading Volume: 2,845,790

Technical Sentiment Signal: Sell

Current Market Cap: £66.78M

For an in-depth examination of ANIC stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1